Related Experiment Video
Updated: Jun 23, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Zygomycosis in neonates: an uncommon but life-threatening infection
Emmanuel Roilides1, Theoklis E Zaoutis, Aspasia Katragkou
13rd Department of Pediatrics, Aristotle University, Thessaloniki, Greece. roilides@med.auth.gr
Abstract:
We systematically reviewed all published cases of zygomycosis, an increasingly important infection with high mortality, in neonates. We searched PubMed and individual references for English publications of single cases or case series of neonatal (0 to 1 month) zygomycosis. Cases were included if they fulfilled prespecified criteria. Fifty-nine cases were published through July 2007. Most of the infants (77%) were premature. The most common sites of zygomycosis were gastrointestinal (54%) and cutaneous (36%) diseases. This pattern differs from sinopulmonary and rhinocerebral patterns of older children. Fifty-six percent of cases were diagnosed by histology only and 44% by histology and culture. RHIZOPUS spp. were isolated from 18/25 (72%) cases. Thirty-seven percent of patients received no antifungal therapy. Thirty-two (54%) neonates underwent surgery with (39%) or without (15%) antifungal agents. Overall mortality was 64%. A higher fraction of neonates treated with amphotericin B and surgery survived than those who received no therapy (70% versus 5%). Zygomycosis is a life-threatening infection in neonates with a distinct pattern of gastrointestinal and cutaneous involvement and high mortality. Combination of amphotericin B and surgery was common management strategy in survivors.
Insights
Neonatal zygomycosis, a serious fungal infection in newborns, commonly affects the gastrointestinal and skin systems. Early treatment with amphotericin B and surgery improves survival rates for this high-mortality condition.
Area of Science:
- Mycology
- Neonatal Medicine
- Infectious Diseases
Background:
- Zygomycosis is a rare but severe fungal infection with high mortality.
- Neonatal cases are increasingly recognized, presenting unique challenges.
Purpose of the Study:
- To systematically review published cases of zygomycosis in neonates.
- To describe the clinical patterns, diagnostic methods, and outcomes of neonatal zygomycosis.
Main Methods:
- Systematic review of English-language publications of neonatal zygomycosis cases (0-1 month).
- Inclusion based on prespecified criteria; data extraction on demographics, clinical presentation, diagnosis, treatment, and outcomes.
- Literature search of PubMed and reference lists up to July 2007.
Main Results:
- Fifty-nine cases were identified; 77% of infants were premature.
- Gastrointestinal (54%) and cutaneous (36%) zygomycosis were most common, differing from older children.
- Overall mortality was 64%; survival was higher with amphotericin B and surgery (70%) versus no therapy (5%).
Conclusions:
- Neonatal zygomycosis is a life-threatening infection with distinct GI and cutaneous patterns.
- High mortality necessitates prompt diagnosis and aggressive management.
- Combination therapy with amphotericin B and surgery appears to improve survival outcomes.
Related Concept Videos
Cryptococcal Meningitis
Fungal Group Zygomycota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Development of the Oral Microbiota
Bacterial Meningitis I: Introduction

